Be Ahead With Economy And Policy Updates
Mumbai: Global pharma major Lupin Limited (Lupin) today announced that it has received the final approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Pitolisant Tablets, 4.45 mg and 17.8 mg.
The U.S. FDA has approved Lupin’s Pitolisant Tablets, 4.45 mg and 17.8 mg, as bioequivalent to Wakix® for the indications in the approved labeling.
You are warmly welcomed to India’s first On-Demand News Platform. We are dedicated to fostering a democracy that encourage diverse opinions and are committed to publishing news for all segments of the society. If you believe certain issues or news stories are overlooked by mainstream media, please write to us. We will ensure your news is published on our platform. Your support would be greatly appreciated if you could provide any relevant facts, images, or videos related to your issue.
Newsletter
India’s thermal coal imports set to fall even as global demand rises: IEA
Major General Gopal Kapoor Visits Garuda Aerospace’s Indigenous Defence Drone Manufacturing Facility
Sigma Advanced Systems Begins Production at Sri City Aerospace Facility; Over 500 Jobs to Be Created
India aims to contribute 10 percent of 6G Global Standards and Patents
IRB Group’s Toll Revenue rises Approx. 25% YoY in August 2026
I’ve tried a few sites lately but this one is surprisingly smooth. The payouts are quick and the interface is easy to navigate. Definitely worth a visit vx7775
Everything from the registration to the actual play was spot on. Very professional setup and fair play. Love using jljl1login.